all 2 news articles
By Ann Knef Will new data dampen enthusiasm for suing drug maker GlaxoSmithKline (GSK) over its diabetes drug Avandia? According to a report by ...
A recent study also suggested that one TZD (rosiglitazone, which is sold as Avandia) might increase the incidence of fatal and non-fatal heart attacks in ...
by Karen Attwood A shock profit warning from GlaxoSmithKline sent its shares plummeting yesterday after the drug giant said "the shadow of Avandia would ...
The Government Accountability Office wants to know if GlaxoSmithKline's diabetes pill Avandia and the cholesterol drug Vytorin -- made by the New ...
Avandia and Vytorin are the subject of yet another government investigation. The Government Accountability Office (GAO) will look into whether the US Food ...
... patients taking TZDs have trended toward lower blood pressure in some studies, previous research has linked the TZD sold as Avandia to heart problems. ...
This view was recently challenged, however, by a study suggesting that TZD rosiglitazone (Avandia) increases cardiovascular events including heart attack ...
Lately, though, biomarkers have become controversial as safety and effectiveness questions arose about meds such as GlaxoSmithKline's Avandia. ...
... Office has agreed to study a much-debated method for approving drugs used to clear GlaxoSmithKline PLC's diabetes pill Avandia and Merck & Co. ...